Secondary progressive multiple sclerosis and Injection site cellulitis

Summary:

Injection site cellulitis is found among people with Secondary progressive multiple sclerosis, especially for people who are male, 40-49 old.

The study analyzes which people have Injection site cellulitis with Secondary progressive multiple sclerosis. It is created by eHealthMe based on reports of 11 people who have Secondary progressive multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Secondary progressive multiple sclerosis?

Secondary progressive multiple sclerosis (a stage of ms which comes after relapsing remitting ms in many cases) is found to be associated with 139 drugs and 131 conditions by eHealthMe. Check the latest studies of Secondary progressive multiple sclerosis.

What is Injection site cellulitis?

Injection site cellulitis (injection site inflammation) is found to be associated with 171 drugs and 305 conditions by eHealthMe. Check the latest studies of Injection site cellulitis.

On Jul, 18, 2026

11 people who have Secondary Progressive Multiple Sclerosis and Injection Site Cellulitis are studied.

Would you have Injection site cellulitis when you have Secondary progressive multiple sclerosis?

Gender of people who have Secondary Progressive Multiple Sclerosis and experienced Injection Site Cellulitis *:

female: 45.45 %
male: 54.55 %

Age of people who have Secondary Progressive Multiple Sclerosis and experienced Injection Site Cellulitis *:

Common co-existing conditions for these people *:

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 36.36%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 36.36%
Gastric Ulcer (stomach ulcer): 4 people, 36.36%
Asthma: 4 people, 36.36%

Common drugs taken by these people *:

Common symptoms for these people *:

Thrombosis (formation of a blood clot inside a blood vessel): 5 people, 45.45%
Weakness: 4 people, 36.36%
Multiple System Atrophy (degeneration of nerve cells in specific areas of the brain): 4 people, 36.36%
Anaemia (lack of blood): 4 people, 36.36%
Blood Potassium Decreased: 4 people, 36.36%
Fatigue (feeling of tiredness): 4 people, 36.36%
Gastric Ulcer (stomach ulcer): 4 people, 36.36%
Influenza Like Illness: 4 people, 36.36%
Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 4 people, 36.36%
Respiratory Tract Infection: 4 people, 36.36%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Injection site cellulitis?

- Check whether Injection site cellulitis is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Injection site cellulitis and Secondary progressive multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.